These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24360189)

  • 21. Serological and virological BVDV prevalence and risk factor analysis for herds to be BVDV seropositive in Belgian cattle herds.
    Sarrazin S; Veldhuis A; Méroc E; Vangeel I; Laureyns J; Dewulf J; Caij AB; Piepers S; Hooyberghs J; Ribbens S; Van Der Stede Y
    Prev Vet Med; 2013 Jan; 108(1):28-37. PubMed ID: 22878124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of economic effects and the health and performance of the general cattle population after exposure to cattle persistently infected with bovine viral diarrhea virus in a starter feedlot.
    Hessman BE; Fulton RW; Sjeklocha DB; Murphy TA; Ridpath JF; Payton ME
    Am J Vet Res; 2009 Jan; 70(1):73-85. PubMed ID: 19119951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-X-C chemokine receptor type 4 and cytokine expressions in cows of a dairy herd with high prevalence of calves persistently infected with bovine viral diarrhea virus.
    Helal MA; Hoshino Y; Takagi S; Tajima M
    Jpn J Vet Res; 2013 Aug; 61(3):109-16. PubMed ID: 24059096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test strategies in bovine viral diarrhea virus control and eradication campaigns in Europe.
    Houe H; Lindberg A; Moennig V
    J Vet Diagn Invest; 2006 Sep; 18(5):427-36. PubMed ID: 17037609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of the eradication program for bovine viral diarrhea in the Swiss dairy sector.
    Thomann B; Tschopp A; Magouras I; Meylan M; Schüpbach-Regula G; Häsler B
    Prev Vet Med; 2017 Sep; 145():1-6. PubMed ID: 28903865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of financial and economic assessments of bovine viral diarrhea virus (BVDV) prevention and mitigation activities worldwide.
    Pinior B; Firth CL; Richter V; Lebl K; Trauffler M; Dzieciol M; Hutter SE; Burgstaller J; Obritzhauser W; Winter P; Käsbohrer A
    Prev Vet Med; 2017 Feb; 137(Pt A):77-92. PubMed ID: 28040270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of bovine viral diarrhea virus infections in alpacas in the United States.
    Topliff CL; Smith DR; Clowser SL; Steffen DJ; Henningson JN; Brodersen BW; Bedenice D; Callan RJ; Reggiardo C; Kurth KL; Kelling CL
    J Am Vet Med Assoc; 2009 Feb; 234(4):519-29. PubMed ID: 19222364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic effects of exposure to bovine viral diarrhea virus on dairy herds in New Zealand.
    Heuer C; Healy A; Zerbini C
    J Dairy Sci; 2007 Dec; 90(12):5428-38. PubMed ID: 18024733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of new bovine viral diarrhea virus introduction on somatic cell count, calving interval, culling, and calf mortality of dairy herds in the Dutch bovine viral diarrhea virus-free program.
    Yue X; van der Voort M; Steeneveld W; van Schaik G; Vernooij JCM; van Duijn L; Hogeveen H
    J Dairy Sci; 2021 Sep; 104(9):10217-10231. PubMed ID: 34147217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between bovine viral diarrhoea virus (BVDV) seropositivity and performance indicators in beef suckler and dairy herds.
    Gates MC; Humphry RW; Gunn GJ
    Vet J; 2013 Dec; 198(3):631-7. PubMed ID: 24269107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of herd structure and type of virus introduction on the spread of bovine viral diarrhoea virus (BVDV) within a dairy herd.
    Ezanno P; Fourichon C; Seegers H
    Vet Res; 2008; 39(5):39. PubMed ID: 18346451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproductive consequences of infection with bovine viral diarrhea virus.
    Grooms DL
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):5-19. PubMed ID: 15062471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of BVDV isolates and factors contributing to virus transmission in the final stage of a BVDV eradication program in lower Austria.
    Rossmanith W; Jacková A; Appel F; Wilhelm E; Vilcek S
    Berl Munch Tierarztl Wochenschr; 2014; 127(1-2):12-8. PubMed ID: 24490338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing biosecurity, health, and culling during dairy herd expansions.
    Faust MA; Kinsel ML; Kirkpatrick MA
    J Dairy Sci; 2001 Apr; 84(4):955-65. PubMed ID: 11352173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herd-level factors associated with the presence of bovine viral diarrhoea virus in herds participating in the voluntary phase of the Irish national eradication programme.
    Graham DA; Clegg TA; Lynch M; More SJ
    Prev Vet Med; 2013 Oct; 112(1-2):99-108. PubMed ID: 23932098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voluntary and compulsory eradication of bovine viral diarrhoea virus in Lower Austria.
    Rossmanith W; Deinhofer M; Janacek R; Trampler R; Wilhelm E
    Vet Microbiol; 2010 Apr; 142(1-2):143-9. PubMed ID: 19931989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of producer and consumer benefits resulting from eradication of bovine viral diarrhoea (BVD) in Scotland, United Kingdom.
    Weldegebriel HT; Gunn GJ; Stott AW
    Prev Vet Med; 2009 Jan; 88(1):49-56. PubMed ID: 18937987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of bovine viral diarrhoea virus control strategies in dairy herds in Hokkaido, Japan, using stochastic modelling.
    Sekiguchi S; Presi P; Omori R; Staerk K; Schuppers M; Isoda N; Yoshikawa Y; Umemura T; Nakayama H; Fujii Y; Sakoda Y
    Transbound Emerg Dis; 2018 Feb; 65(1):e135-e144. PubMed ID: 28805020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal risk management versus willingness to pay for BVDV control options.
    Santarossa JM; Stott AW; Humphry RW; Gunn GJ
    Prev Vet Med; 2005 Nov; 72(1-2):183-7; discussion 215-9. PubMed ID: 16169618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.